{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:28:00Z","timestamp":1762867680710,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.endien.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:36:18Z","timestamp":1646382978000},"page":"157-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Asymptomatic carriers of mutations in succinate dehydrogenase (SDHx) genes. In search of consensus for follow-up"],"prefix":"10.1016","volume":"69","author":[{"given":"Elena","family":"Navarro Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Romero Lluch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Caster\u00e1s Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2022.01.008_bib0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endrocr Rev."},{"key":"10.1016\/j.endien.2022.01.008_bib0010","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2022.01.008_bib0015","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2022.01.008_bib0020","first-page":"1","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"20","author":"N\u00f6lting","year":"2021","journal-title":"Endocr Rev."},{"key":"10.1016\/j.endien.2022.01.008_bib0025","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/s41436-020-0921-3","article-title":"Tumor detection rates in screening of individuals th SDHx-related hereditary paraganglioma-pheochromocytoma syndrome","volume":"22","author":"Greenberg","year":"2020","journal-title":"Genet Med."},{"key":"10.1016\/j.endien.2022.01.008_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/cen.14184","article-title":"Surveillance of succinate dehydrogenase gene mutation carriers: insigts for a nationwide cohort","volume":"92","author":"Martins","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.endien.2022.01.008_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.13877","article-title":"Can subunit specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?","volume":"90","author":"Tufton","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.endien.2022.01.008_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/joim.12869","article-title":"Genetic testin and surveillance guidelines in hereditary pheochromocytoma and paraganglioma","volume":"285","author":"Muth","year":"2019","journal-title":"J Intern Med."},{"key":"10.1016\/j.endien.2022.01.008_bib0045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endien.2022.01.008_bib0050","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/cen.14289","article-title":"A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: beyond phaeochromocytoma and paraganglioma","volume":"93","author":"MacFarlane","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.endien.2022.01.008_bib0055","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1093\/hmg\/ddaa201","article-title":"Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precisi\u00f3n medicine","volume":"29","author":"Sey","year":"2020","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.endien.2022.01.008_bib0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol."},{"issue":"Espec Cong 2","key":"10.1016\/j.endien.2022.01.008_bib0065","first-page":"9","article-title":"Resultados de un protocolo multic\u00e9ntrico de seguimiento de portadores no \u00edndices de mutaciones en succinato deshidrogenasa (SDH) B Y C Comunicaci\u00f3n oral 60 Congreso Nacional Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n","volume":"66","author":"Romero-Lluch","year":"2019","journal-title":"Endocrinol Diabetes Nutr."},{"key":"10.1016\/j.endien.2022.01.008_bib0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-17-0077","article-title":"Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma","volume":"177","author":"Rao","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2022.01.008_bib0075","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.endien.2022.01.008_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cen.14375","article-title":"PET detectives: molecular imaging for phaeochromocytomas and paragangliomas in the genomics era","volume":"95","author":"Ryder","year":"2021","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.endien.2022.01.008_bib0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-16-0595","article-title":"Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations","volume":"175","author":"Daniel","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2022.01.008_bib0090","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s00330-015-4024-5","article-title":"The value of a rapid contrast-enhanced angio MRI protocol in the detection of head and paragangliomas in SDHx mutations carriers: a retrospective study un behalf of the PGL.EVA investigators","volume":"26","author":"Gravel","year":"2016","journal-title":"Eur Radiol."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:15:54Z","timestamp":1762866954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018022000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2530018022000440"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2022.01.008","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymptomatic carriers of mutations in succinate dehydrogenase (SDHx) genes. In search of consensus for follow-up","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2022.01.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}